-+ 0.00%
-+ 0.00%
-+ 0.00%

JAZZ PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED PRIVATE OFFERING OF $1.1 BILLION OF 1.875% EXCHANGEABLE SENIOR NOTES DUE 2032 AND CONCURRENT ORDINARY SHARE REPURCHASES

Reuters·08/27/2026 04:30:00

Please log in to view news